Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
The Oncologist|May 8, 2015
Observations on Three Endpoint Properties and Their Relationship to Regulatory Outcomes of European Oncology Marketing ApplicationsLawrence Liberti, Pieter Stolk, James Neil McAuslane, et al.Frontiers in Pharmacology|April 20, 2017
FDA Facilitated Regulatory Pathways: Visualizing Their Characteristics, Development, and Authorization TimelinesLawrence Liberti, Magda Bujar, Alasdair Breckenridge, et al.Patient Preference and Adherence|August 28, 2018
Effect of different methods for estimating persistence and adherence to new glucose-lowering drugs: results of an observational, inception cohort study in PortugalCarla Torre, José Guerreiro, Patrícia Longo, et al.European Journal of Clinical Pharmacology|June 25, 2015
Influence of point estimates and study power of bioequivalence studies on establishing bioequivalence between generics by adjusted indirect comparisonsLuther Gwaza, John Gordon, Henrike Potthast, et al.Scientia Pharmaceutica|July 15, 2015
Licensing of Generic Medicines: Are There Any Challenges Left? A Pharmaceutical Regulatory PerspectiveJohn Joseph Borg, Paolo Tomasi, Luca Pani, et al.Antiviral Therapy|September 21, 2016
Interchangeability between first-line generic antiretroviral products prequalified by WHO using adjusted indirect comparisonsLuther Gwaza, John Gordon, Jan Welink, et al.Primary Care Diabetes|April 26, 2015
Patterns of glucose lowering drugs utilization in Portugal and in the Netherlands. Trends over timeCarla Torre, José Guerreiro, Sofia de Oliveira Martins, et al.Drug Safety|July 6, 2016
Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?Linda Härmark, June Raine, Hubert Leufkens, et al.British Journal of Clinical Pharmacology|February 19, 2008
Use of beta2 agonists and risk of acute myocardial infarction in patients with hypertensionFrank de Vries, Sander Pouwels, Madelon Bracke, et al.Journal of Hypertension|December 20, 2007
Use of inhaled corticosteroids and the risk of non-fatal acute myocardial infarctionFrank de Vries, Sander Pouwels, Madelon Bracke, et al.Pageof 4